Identifying the Optimal Gamma-Delta Donor Through a Strategic Screening Approach

4:15 pm - Wednesday 19th November 2025

  • Understanding the key phenotypic traits that define an ideal Gamma-Delta T-cell donor for therapeutic use
  • Learning how a structured screening strategy is used to characterize and select top-performing donors
  • Exploring how donor variability impacts cell expansion and potency, informing better CAR-T development

Speakers:

Chief Executive Officer
Luminary Therapeutics